 
(c) template SR.12.01.01 of Annex I, specifying information on life and health SLT technical provisions for each line of 
business as defined in Annex I of Delegated Regulation (EU) 2015/35, following the instructions set out in section 
S.12.01 of Annex II to this Regulation;  
(d) template SR.17.01.01 of Annex I, specifying information on non-life technical provisions for each line of business 
as defined in Annex I of Delegated Regulation (EU) 2015/35, following the instructions set out in section S.17.01 
of Annex II to this Regulation;  
(e) template SR.22.02.01 of Annex I, specifying information on the projection of future cash flows for the best 
estimate calculation by each material matching adjustment portfolio, following the instructions set out in 
section S.22.02 of Annex II;  
(f) template SR.22.03.01 of Annex I, specifying information on the matching adjustment portfolios by each material 
matching adjustment portfolio, following the instructions set out in section S.22.03 of Annex II;  
(g) where the undertaking uses the standard formula for the calculation of the Solvency Capital Requirement, template 
SR.25.01.01 of Annex I, specifying the Solvency Capital Requirement, following the instructions set out in 
section S.25.01 of Annex II;  
(h) where the undertaking uses the a partial internal model or a full internal model for the calculation of the Solvency 
Capital Requirement, template SR.25.05.01 of Annex I, specifying the Solvency Capital Requirement, following the 
instructions set out in section S.25.05 of Annex II;  
(i) template SR.26.01.01 of Annex I, specifying information on market risk, following the instructions set out in 
section S.26.01 of Annex II;  
(j) template SR.26.02.01 of Annex I, specifying information on counterparty default risk, following the instructions set 
out in section S.26.02 of Annex II;  
(k) template SR.26.03.01 of Annex I, specifying information on life underwriting risk, following the instructions set 
out in section S.26.03 of Annex II;  
(l) template SR.26.04.01 of Annex I, specifying information on health underwriting risk, following the instructions set 
out in section S.26.04 of Annex II;  
(m) template SR.26.05.01 of Annex I, specifying information on non-life underwriting risk, following the instructions 
set out in section S.26.05 of Annex II;  
(n) template SR.26.06.01 of Annex I, specifying information on operational risk, following the instructions set out in 
section S.26.06 of Annex II;  
(o) template SR.26.07.01 of Annex I, specifying information on the simplifications used in the calculation of the 
Solvency Capital Requirement, following the instructions set out in section S.26.07 of Annex II;  
(p) for undertakings using a partial internal model or a full internal model, template SR.26.08.01 of Annex I, specifying 
further information on the internal model used for the Solvency Capital Requirement, following the instructions set 
out in section S.26.08 of Annex II;  
(q) template SR.27.01.01 of Annex I, specifying information on non-life catastrophe risk, following the instructions set 
out in section S.27.01 of Annex II.  
2. Where a partial internal model is used, the information in the templates referred to in paragraph 1, points (i) to (o) 
and (q), shall only be reported in relation to the risks covered by the standard formula and the information in the 
template referred to in paragraph 1, point (p), shall be reported in relation to the risks covered by the internal model.EN  5.5.2023 Official Journal of the European Union L 120/17